Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 217675
Company: JUBILANT CADISTA

Products on ANDA 217675

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
METHENAMINE HIPPURATE	METHENAMINE HIPPURATE	1GM	TABLET;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 217675

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
12/01/2023	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 217675

METHENAMINE HIPPURATE

TABLET;ORAL; 1GM
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
HIPREX	METHENAMINE HIPPURATE	1GM	TABLET;ORAL	Prescription	Yes	AB	017681	SS PHARMA
METHENAMINE HIPPURATE	METHENAMINE HIPPURATE	1GM	TABLET;ORAL	Prescription	No	AB	205661	AUROBINDO PHARMA LTD
METHENAMINE HIPPURATE	METHENAMINE HIPPURATE	1GM	TABLET;ORAL	Prescription	No	AB	217675	JUBILANT CADISTA
METHENAMINE HIPPURATE	METHENAMINE HIPPURATE	1GM	TABLET;ORAL	Prescription	No	AB	212172	MICRO LABS
METHENAMINE HIPPURATE	METHENAMINE HIPPURATE	1GM	TABLET;ORAL	Prescription	No	AB	210068	NOVAST LABS
UREX	METHENAMINE HIPPURATE	1GM	TABLET;ORAL	Prescription	No	AB	016151	ALVOGEN